19-16896503-C-A

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_015692.5(CPAMD8):​c.5228G>T​(p.Arg1743Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000743 in 1,426,424 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000066 ( 1 hom., cov: 31)
Exomes 𝑓: 0.000075 ( 1 hom. )

Consequence

CPAMD8
NM_015692.5 missense

Scores

1
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.567
Variant links:
Genes affected
CPAMD8 (HGNC:23228): (C3 and PZP like alpha-2-macroglobulin domain containing 8) This gene encodes a member of the protease inhibitor I39 (alpha-2-macroglobulin) family of proteins. These proteins are important in innate and acquired immunity. The encoded protein is membrane-associated and proteolytically processed to generate two chains. Mutations in this gene cause a form of anterior segment dysgenesis, a developmental disorder of the eye. [provided by RefSeq, May 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004871875).
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0000657 (10/152168) while in subpopulation SAS AF= 0.00207 (10/4830). AF 95% confidence interval is 0.00112. There are 1 homozygotes in gnomad4. There are 5 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CPAMD8NM_015692.5 linkuse as main transcriptc.5228G>T p.Arg1743Leu missense_variant 40/42 ENST00000443236.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CPAMD8ENST00000443236.7 linkuse as main transcriptc.5228G>T p.Arg1743Leu missense_variant 40/421 NM_015692.5 P2Q8IZJ3-1

Frequencies

GnomAD3 genomes
AF:
0.0000658
AC:
10
AN:
152060
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000271
AC:
11
AN:
40540
Hom.:
0
AF XY:
0.000232
AC XY:
5
AN XY:
21596
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00194
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00136
GnomAD4 exome
AF:
0.0000753
AC:
96
AN:
1274256
Hom.:
1
Cov.:
32
AF XY:
0.000108
AC XY:
67
AN XY:
621686
show subpopulations
Gnomad4 AFR exome
AF:
0.0000391
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00123
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000194
Gnomad4 OTH exome
AF:
0.000342
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152168
Hom.:
1
Cov.:
31
AF XY:
0.0000672
AC XY:
5
AN XY:
74410
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000113
ExAC
AF:
0.000105
AC:
2
Asia WGS
AF:
0.00290
AC:
10
AN:
3466

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 23, 2024The c.5369G>T (p.R1790L) alteration is located in exon 40 (coding exon 40) of the CPAMD8 gene. This alteration results from a G to T substitution at nucleotide position 5369, causing the arginine (R) at amino acid position 1790 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
12
DANN
Benign
0.92
Eigen
Benign
-0.96
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.66
T;T
M_CAP
Benign
0.0084
T
MetaRNN
Benign
0.0049
T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.74
T
Sift4G
Benign
0.086
T;.
Vest4
0.13
MVP
0.11
MPC
1.6
ClinPred
0.021
T
GERP RS
-1.3

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs549968603; hg19: chr19-17007314; API